Answers are grounded in this paper and cite their sources.
Background: Steroid-resistant nephrotic syndrome (SRNS) is a common problem in paediatric nephrology practice which tends to progress to end-stage renal disease. SRNS-causing genes are expressed in the glomerular podocyte which is a specialized cell type. However, there are more than 80% of SRNS cases with unknown molecular etiology. Coenzyme Q10 (CoQ10) has an important role in the mitochondrial electron-transport chain. Synthesis of CoQ10 is a complex pathway, involving enzymes from various genomes; termed from CoQ1 to CoQ10. Due to sequenced reactions of synthesis, enzymes and regulatory proteins are needed in obligation. So any dysfunction here; affects the biosynthesis of CoQ10. Aim: We here described quinone-responsive six patients having CoQ2 mutations, presented with steroid-resistant NS. Findings: CoQ 10 deficiency is strongly related with CoQ2 deficiency and/or any mutation of encoding genes. Among the 5 types of CoQ 10 deficiency, infantile form can be presented only with renal involvement, nephrotic syndrome. Also in other forms, renal involvement is not rare besides the neurological pathologies. All 6 cases of us with CoQ2 mutation responded to CoQ 10 treatment. Conclusions: In conclusion, early recognition of CoQ2 nephropathy is crucial. CoQ10 supplementation improves the clinical symptoms and prevents neurologic complications. Long-term follow-up is important to define the prognosis of these patients.
No takes yet. Share an insight, caveat, or question.
Dinçel et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: